Moreover, obesity, NAFLD and nonalcoholic steatohepatitis (NASH) are all accompanied by elevated chemerin levels, while attenuating these conditions lowers chemerin [72,77,113,114]. This evidence concerns the gene RARRES2 and metabolic dysfunction-associated steatohepatitis.